Veterinary/Animal Vaccines Market Research Report - Global Forecast till 2027

Veterinary/Animal Vaccines Market Information: By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Global Forecast till 2027

ID: MRFR/Pharma/1994-CR | May 2019 | Region: Global | 133 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

The Global Veterinary/Animal Vaccines Market is expected to register a CAGR of 6.38% to reach USD 9,910.59 million by 2025. Veterinary vaccines are used to prevent infectious diseases caused by various causing agents and to provide protection to animals from various life-threatening disorders. Majority of the products are used for immunization of companion animals, ruminants, swine, poultry, and aquaculture. Veterinary vaccination has been proved helpful in the prevention of outbreak of livestock diseases.


An increasing number of pet owners, growing livestock population and disease outbreaks have led to the growth of the global veterinary/animal vaccines market in recent years. However, high storage cost associated with veterinary vaccines is likely to restrain the market growth over the forecast period.


Synopsis/Market Dynamics


Rising adoption of companion animals, growing livestock population, and outbreaks of livestock diseases coupled with several advances in technology in veterinary vaccines, and various initiatives by government agencies, animal associations will support the market growth in the forecast period. Recently, in 2017, the number of companion animals consisted of 11 million cats and 26.8 million dogs in China, and 13.1 million dogs and 9.8 million cats in Japan. According to the World Society for the Protection of Animals (WSPA), presently, just 25,000 dogs are living in homes in Republic of Chad, Africa, and 7.4 million dogs and 2 million cats in South Africa.


Global Veterinary/Animal Vaccines Market Revenue, by Type, 2017 (USD Mn) Global Veterinary/Animal Vaccines Market Revenue, by Type, 2017


Source: MRFR Analysis


The livestock vaccines segment was the largest segment of the veterinary/animal vaccines market in 2017, valued at USD 1,558.94 million in 2017.


Segmentation


The global veterinary/animal vaccines market has been segmented into type, technology, and region. Based on type, the veterinary/animal vaccines market has been segmented into livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, and aquaculture vaccines. Based on technology, the global veterinary/animal vaccines market has been segmented into a live attenuated vaccine, inactivated vaccines, recombinant vaccines, and toxoid vaccines.


Asia-Pacific Veterinary/Animal Vaccines Market Share, by Countries, 2017 (%) Asia-Pacific Veterinary/Animal Vaccines Market Share, by Countries


Source: MRFR Analysis


Regional Analysis


The global veterinary/animal vaccines market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is expected to dominate the global veterinary/animal vaccines market. This is owing to the increasing number of pet owners, and growing livestock population and disease outbreaks. Asia-Pacific is estimated to be the fastest growing region in the market. This is owing to the growing penetration of the veterinary sector, surging number of private veterinary clinics, increasing awareness about animal welfare, and rising non-governmental organizations’ (NGOs) work for the welfare of animals. On the other hand, the Middle East & Africa has the least share in the veterinary/animal vaccines market.

Key Players

The prominent players in the global veterinary/animal vaccines market are Boehringer Ingelheim International GmbH (Germany), Zoetis (US), Ceva (US), MSD & Co. Inc (US), Elanco (US), Virbac (France), Phibro Animal Health Corporation (US) Hipra (Spain), IDT Biologika GmbH (Germany), Biogenesis Bago SA (Argentina), and others.


Some of the key strategies followed by the players operating in the global veterinary/animal vaccines market were product launches, acquisitions, and expansion.


  • In January 2019, Boehringer Ingelheim International GmbH built its commercial biologics manufacturing unit in China and launched its first veterinary vaccine in the country.

  • In September 2018, MSD & Co. Inc. launched the PRIME PAC PRRS RR vaccine for porcine reproductive and respiratory syndrome virus (PRRS).

  • In June 2017, Virbac collaborated with Bio-Gene Technology for the research and development of animal health products.


 


Market Segmentation

Global Veterinary/Animal Vaccines Market, by Type



  • Livestock Vaccines

  • Porcine Vaccines

  • Companion Animal Vaccines

  • Poultry Vaccines

  • Aquaculture Vaccines


Global Veterinary/Animal Vaccines Market, by Technology



  • Live Attenuated Vaccine

  • Inactivated Vaccines

  • Recombinant Vaccines

  • Toxoid Vaccines


Global Veterinary/Animal Vaccines Market, by Region



  • Americas

    • North America

      • US

      • Canada

      • South America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Company Profiles of Other Key Players



  1. Eli Lilly and Company

  2. Bayer AG

  3. Neogen Corporation

  4. ImmuCell Corporation



  • Investment Opportunities in Veterinary/Animal Vaccines Market


Intended Audience



  • Veterinary Vaccines Manufacturing Companies

  • Research Institutes

  • Veterinary Hospitals



1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 18

3.2 Scope of the Study 18

3.3 Research Objective 18

3.4 Assumptions & Limitations 18

3.4.1 Assumptions 18

3.4.2 Limitations 18

3.5 Market Structure 19

4 Research Methodology

4.1 Research Process 21

4.2 Primary Research 22

4.3 Secondary Research 23

4.4 Market Size Estimation 24

4.5 Forecast Model 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 27

5.2.1 Increasing Number of Pet Owners 27

5.2.2 Growing Livestock Population and Disease Outbreaks 27

5.2.3 Advances in Technology underlying Veterinary Vaccines 27

5.2.4 Various Initiatives by Several Government Agencies, Animal Associations, and Prominent Market Players 28

5.3 Restraint 28

5.3.1 High Storage Cost associated with Veterinary Vaccines 28

5.4 Opportunity 28

5.4.1 Rising Investments to Improve Animal Health 28

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 30

6.1.1 Bargaining Power of Suppliers 30

6.1.2 Bargaining Power of Buyers 31

6.1.3 Threat of New Entrants 31

6.1.4 Threat of Substitutes 31

6.1.5 Rivalry 31

6.2 Supply Chain Analysis 31

6.2.1 R&D and Development 32

6.2.2 Manufacturing 32

6.2.3 Distribution & Sales 32

6.2.4 Post-Sales Monitoring 32

7 Veterinary/Animal Vaccines Market, by Type

7.1 Introduction 35

7.1.1 Livestock Vaccines 37

7.1.2 Porcine Vaccines 38

7.1.3 Companion Animal Vaccines 38

7.1.4 Poultry Vaccines 39

7.1.5 Aquaculture Vaccines 39

8 Veterinary/Animal Vaccines Market, by Technology

8.1 Introduction 41

8.1.1 Live Attenuated Vaccines 43

8.1.2 Inactivated Vaccines 43

8.1.3 Recombinant Vaccines 44

8.1.4 Toxoid Vaccines 44

9 Global Veterinary/Animal Vaccines Market, by Region

9.1 Introduction 46

9.2 Americas 48

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.2.1 North America 51

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.2.1.1 US 53

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.2.1.2 Canada 55

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.2.2 South America 57

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3 Europe 60

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1 Western Europe 63

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.1 France 65

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.2 Germany 67

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.3 UK 69

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.4 Spain 71

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.5 Italy 73

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.1.6 Rest of Western Europe 75

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.3.2 Eastern Europe 77

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4 Asia-Pacific 80

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.1 Japan 83

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.2 China 85

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.3 India 87

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.4 Australia 89

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.5 Republic of Korea 91

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.4.6 Rest of Asia-Pacific 93

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.5 Middle East and Africa 95

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.5.1 Middle East 98

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

9.5.2 Africa 100

Veterinary/Animal Vaccines Market, by Type

Veterinary/Animal Vaccines Market, by Technology

10 Competitive Landscape

10.1 Introduction 103

11 Company Profiles

11.1 Boehringer Ingelheim International GmbH 106

11.1.1 Company Overview 106

11.1.2 Financial Overview 106

11.1.3 Products/Services Offered 107

11.1.4 Key Developments 107

11.1.5 SWOT Analysis 107

11.1.6 Key Strategies 107

11.2 Zoetis 108

11.2.1 Company Overview 108

11.2.2 Financial Overview 108

11.2.3 Products/Services Offered 109

11.2.4 Key Developments 109

11.2.5 SWOT Analysis 110

11.2.6 Key Strategies 110

11.3 Ceva 111

11.3.1 Company Overview 111

11.3.2 Financial Overview 111

11.3.3 Products/Services Offered 112

11.3.4 Key Developments 112

11.3.5 SWOT Analysis 113

11.3.6 Key Strategies 113

11.4 MSD & Co. Inc. 114

11.4.1 Company Overview 114

11.4.2 Financial Overview 114

11.4.3 Products/Services Offered 115

11.4.4 Key Developments 116

11.4.5 SWOT Analysis 116

11.4.6 Key Strategies 116

11.5 Elanco 117

11.5.1 Company Overview 117

11.5.2 Financial Overview 117

11.5.3 Products/Services Offered 118

11.5.4 Key Developments 118

11.5.5 SWOT Analysis 118

11.5.6 Key Strategies 119

11.6 Virbac 120

11.6.1 Company Overview 120

11.6.2 Financial Overview 120

11.6.3 Products/Services Offered 121

11.6.4 Key Developments 121

11.6.5 SWOT Analysis 121

11.6.6 Key Strategies 121

11.7 Phibro Animal Health Corporation. 122

11.7.1 Company Overview 122

11.7.2 Financial Overview 122

11.7.3 Products/Services Offered 123

11.7.4 Key Developments 123

11.7.5 SWOT Analysis 123

11.7.6 Key Strategies 123

11.8 Hipra 124

11.8.1 Company Overview 124

11.8.2 Financial Overview 124

11.8.3 Products/Services Offered 124

11.8.4 Key Developments 125

11.8.5 SWOT Analysis 125

11.8.6 Key Strategies 125

11.9 IDT Biologika GmbH 126

11.9.1 Company Overview 126

11.9.2 Financial Overview 126

11.9.3 Products/Services Offered 126

11.9.4 Key Developments 126

11.9.5 SWOT Analysis 127

11.9.6 Key Strategies 127

11.10 Biogenesis Bago SA 128

11.10.1 Company Overview 128

11.10.2 Financial Overview 128

11.10.3 Products/Services Offered 128

11.10.4 Key Developments 128

11.10.5 SWOT Analysis 129

11.10.6 Key Strategies 129

12 Appendix

12.1 Discussion Blue Print 131

13 List of Tables

TABLE 1 MARKET SYNOPSIS 16

TABLE 2 PRIMARY INTERVIEWS 21

TABLE 3 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 36

TABLE 5 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 37

TABLE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR PORCINE VACCINES, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY REGION, 2020–2027

(USD MILLION) 38

TABLE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR POULTRY VACCINES, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR AQUACULTURE VACCINES, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 42

TABLE 12 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR LIVE ATTENUATED VACCINES, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR INACTIVATED VACCINES, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 14 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR RECOMBINANT VACCINES, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 15 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FOR TOXOID VACCINES, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 17 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 18 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 19 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 20 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 50

TABLE 21 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 50

TABLE 22 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51

TABLE 23 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 24 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 25 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 52

TABLE 26 NORTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 53

TABLE 27 US: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 28 US: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 29 US: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 30 US: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 55

TABLE 31 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 32 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 33 CANADA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 34 CANADA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57

TABLE 35 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 36 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 37 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 58

TABLE 38 SOUTH AMERICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 59

TABLE 39 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 60

TABLE 40 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 41 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 42 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 43 EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 62

TABLE 44 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 45 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 46 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 47 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 64

TABLE 48 WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 65

TABLE 49 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 50 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 51 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 52 FRANCE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 67

TABLE 53 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 54 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 55 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 68

TABLE 56 GERMANY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69

TABLE 57 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 58 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 59 UK: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 60 UK: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71

TABLE 61 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 62 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 63 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 64 SPAIN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73

TABLE 65 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 66 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 67 ITALY: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 68 ITALY: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 75

TABLE 69 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 70 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027

(USD MILLION) 76

TABLE 71 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 72 REST OF WESTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 77

TABLE 73 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 74 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 75 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 78

TABLE 76 EASTERN EUROPE: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 79

TABLE 77 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80

TABLE 78 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 79 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 80 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 82

TABLE 81 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 82

TABLE 82 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 83 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 84 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 85 JAPAN: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 84

TABLE 86 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 87 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 88 CHINA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 89 CHINA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 86

TABLE 90 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 91 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 92 INDIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 93 INDIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88

TABLE 94 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 95 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 96 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 90

TABLE 97 AUSTRALIA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90

TABLE 98 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 99 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027

(USD MILLION) 91

TABLE 100 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 92

TABLE 101 REPUBLIC OF KOREA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92

TABLE 102 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 103 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027

(USD MILLION) 93

TABLE 104 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 94

TABLE 105 REST OF ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 94

TABLE 106 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 95

TABLE 107 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 108 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027

(USD MILLION) 96

TABLE 109 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 110 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 97

TABLE 111 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 112 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 113 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027

(USD MILLION) 99

TABLE 114 MIDDLE EAST: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 99

TABLE 115 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 116 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 117 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 118 AFRICA: VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 101

14 List of Figures

FIGURE 1 RESEARCH PROCESS 21

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 24

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VETERINARY/ANIMAL VACCINES MARKET 26

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL VETERINARY/ANIMAL VACCINES MARKET 30

FIGURE 5 SUPPLY CHAIN: GLOBAL VETERINARY/ANIMAL VACCINES MARKET 32

FIGURE 6 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 (% SHARE) 35

FIGURE 7 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 & 2027 35

FIGURE 8 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TECHNOLOGY,2020 (% SHARE) 41

FIGURE 9 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY TYPE, 2020 & 2027 42

FIGURE 10 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020 (% SHARE) 46

FIGURE 11 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46

FIGURE 12 AMERICAS: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 48

FIGURE 13 EUROPE: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 60

FIGURE 14 ASIA-PACIFIC: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 80

FIGURE 15 MIDDLE EAST AND AFRICA: VETERINARY/ANIMAL VACCINES MARKET SHARE, BY REGION, 2020 (% SHARE) 95

FIGURE 16 GLOBAL VETERINARY/ANIMAL VACCINES MARKET, MARKET SHARE ANALYSIS 2020 (%) 103